87
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Modulation of Murine Peritoneal Macrophage Function by Chronic Exposure to Arsenate in Drinking Water

, , &
Pages 315-330 | Published online: 08 Oct 2008

REFERENCES

  • IARC (International Agency for Research on Cancer) Arsenic and arsenic compounds. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluation of Carcinogenicity. An Updating of IARC Monograph 1 to 42; International Agency for Research on Cancer: LyonFrance, 1987; 100–106. suppl. 7.
  • NTP arsenic and certain arsenic compounds. In Reports on Carcinogens, First and Subsequent 2nd–9th (1980–2000); National Toxicology Program: Research Triangle Park, NC, 2000; 17–19.
  • Tseng, W. P. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19, 109–119. [PUBMED], [INFOTRIEVE]
  • Irgolic, K. J. Determination of total arsenic and arsenic compounds in drinking water. In Arsenic Exposure and Health; Chappell, W.R., Abernathy, C.O., Cothern, C.R., Eds.; Science and Technology Letters: NorthwoodUK, 1994; 51–60.
  • Das, D.; Chatterjee, A.; Mandal, B.K.; Samanta, G.; Chakraborti, D.; Chanda, B. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 1995, 120 (3), 917–924. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Ng, J. C.; Seawright, A.A.; Qi, L.; Garnett, C.M.; Chiswell, B.; Moore, M.R. In Tumours in mice induced by chronic exposure of high arsenic concentration in drinking water: abstract, Third International Conference on Arsenic-Exposure and Health Effects, San Diego, CAUSA, July 1998.
  • Wei, M.; Wanibuchi, H.; Yamamoto, S.; Li, W.; Fukushima, S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F334 rats. Carcinogenesis 1999, 20 (9), 1873–1876. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Wang, J. P.; Qi, L.; Moore, M.R.; Ng, J.C. A review of animal models for the study of arsenic carcinogenesis. Toxicol. Lett. 2002, 133 (1), 17–31. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Li, J. H.; Rossman, T.G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 1989, 2 (1), 1–9. [PUBMED], [INFOTRIEVE], [CSA]
  • Hu, Y.; Su, L.; Snow, E. T. Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat. Res. 1998, 408 (3), 203–218. [PUBMED], [INFOTRIEVE]
  • Hartwig, A.; Groblinghoff, U. D.; Beyersmann, D.; Natarajan, A.T.; Filon, R.; Mullenders, L.H. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997, 18 (2), 399–405. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Sikorski, E. E.; McCay, J.A.; White, K.L., Jr.; Bradley, S.G.; Munson, A.E. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam. Appl. Toxicol. 1989, 13 (4), 843–858. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Burns, L. A.; Sikorski, E.E.; Saady, J.J.; Munson, A.E. Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 1991, 110 (1), 157–169. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Hossain, K.; Akhand, A.A.; Kato, M.; Du, J.; Takeda, K.; Wu, J.; Takeuchi, K.; Liu, W.; Suzuki, H.; Nakashima, I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-jun amino-terminal kinase. J. Immunol. 2000, 165 (8), 4290–4297. [PUBMED], [INFOTRIEVE]
  • Chen, G.Q.; Zhu, J.; Shi, X.G.; Ni, J.H.; Zhong, H.J.; Si, G.Y.; Jin, X.L.; Tang, W.; Li, X.S.; Xong, S.M.; Shen, Z.X.; Sun, G.L.; Ma, J.; Zhang, P.; Zhang, T.D.; Gazin, C.; Naoe, T.; Chen, S.J.; Wang, Z.Y.; Chen, Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996, 88 (3), 1052–1061. [PUBMED], [INFOTRIEVE], [CSA]
  • Goytia-Acevedo, R. C.; Cebrian, M.E.; Calderon-Aranda, E.S. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes. Toxicology 2003, 189 (3), 235–244. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Vega, L.; Ostrosky-Wegman, P.; Fortoul, T.I.; Diaz, C.; Madrid, V.; Saavedra, R. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol. Immunotoxicol. 1999, 21 (2), 203–220. [PUBMED], [INFOTRIEVE], [CSA]
  • Gonsebatt, M.E.; Vega, L.; Herrera, L.A.; Montero, R.; Rojas, E.; Cebrian, M.E.; Ostrosky-Wegman, P. Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat. Res. 1992, 283 (2), 91–95. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gonsebatt, M.E.; Vega, L.; Montero, R.; Garcia-Vargas, G.; Del Razo, L.M.; Albores, A.; Cebrian, M.E.; Ostrosky-Wegman, P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat. Res. 1994, 313 (2–3), 293–299. [PUBMED], [INFOTRIEVE]
  • Sakurai, T.; Kaise, T.; Matsubara, C. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 1998, 11 (4), 273–283. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Sakurai, T.; Kaise, T.; Ochi, T.; Saitoh, T.; Matsubara, C. Study of in vitro cytotoxicity of a water soluble organic arsenic compound, arsenosugar, in seaweed. Toxicology 1997, 122 (3), 205–212. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Bishayi, B.; Sengupta, M. Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in arsenic and lead intoxicated mature Swiss albino mice. Toxicology 2003, 184 (1), 31–39. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Biswas, B.K.; Dhar, R.K.; Samanta, G.; Mandal, B.K.; Chakraborti, D.; Faruk, I.; Islam, K.S.; Chowdhury, M.M.; Islam, A.; Roy, S. Detailed study report of Samta, one of the arsenic-affected villages of Jessore District, Bangladesh. Curr. Sci. 1998, 74, 134–145.
  • Nathan, C.; Xie, Q. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78 (6), 915–918. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Rook, G. A.W.; Steele, J.; Umar, S.; Dockrell, H.M. A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by γ-interferon. J. Immunol. Methods 1985, 82 (1), 161–167. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Dahlgren, C.; Karlsson, A. Respiratory burst in human neutrophils. J. Immunol. Methods 1999, 232 (1–2), 3–14. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • MacMicking, J.; Xie, Q.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323–350. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Buchet, J.P.; Lauwerys, R. Study of inorganic arsenic methylation by rat in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 1985, 57 (2), 125–129. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Styblo, M.; Del Razo, L. M.; Vega, L.; Germolec, D.R.; LeCluyse, E.L.; Hamilton, G.A.; Reed, W.; Wang, C.; Cullen, W.R.; Thomas, D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74 (6), 289–299. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Snow, E. T. Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 1992, 53 (1), 31–65. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Cavigelli, M.; Li, W.W.; Lin, A.; Su, B.; Yoshioka, K.; Karin, M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 1996, 15 (22), 6269–6279. [PUBMED], [INFOTRIEVE], [CSA]
  • Gebel, T. W. Genotoxicity of arsenical compounds. Int. J. Hyg. Environ. Health 2001, 203 (3), 249–262. [PUBMED], [INFOTRIEVE], [CSA]
  • Soignet, S.L.; Frankel, S.R.; Douer, D.; Tallman, M.S.; Kantarjian, H.; Calleja, E.; Stone, R.M.; Kalaycio, M.; Scheinberg, D.A.; Steinherz, P.; Sievers, E.L.; Coutre, S.; Dahlberg, S.; Ellison, R.; Warrell, R.P., Jr. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 2001, 19 (18), 3852–3860. [PUBMED], [INFOTRIEVE]
  • Fan, D.; Liaw, A.; Denkins, Y. M.; Collins, J.H.; Van Arsdall, M.; Chang, J.L.; Chakrabarty, S.; Nguyen, D.; Kruzel, E.; Fidler, I.J. Type-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma. J. Exp. Ther. Oncol. 2002, 2 (5), 286–297. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Tsung, K.; Dolan, J. P.; Tsung, Y.L.; Norton, J.A. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res. 2002, 62 (17), 5069–5075. [PUBMED], [INFOTRIEVE]
  • Chiou, H. Y.; Hsueh, Y.M.; Hsieh, L.L.; Hsu, L.I.; Hsu, Y.H.; Hsieh, F.I.; Wei, M.L.; Chen, H.C.; Yang, H.T.; Leu, L.C.; Chu, T.H.; Chen-Wu, C.; Yang, M.H.; Chen, C.J. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat. Res. 1997, 386 (3), 197–207. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kolb, H.; Kolb-Bachofen, V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol. Today 1998, 19 (12), 556–561. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Lorsbach, R. B.; Murphy, W.J.; Lowenstein, C.J.; Snyder, S.H.; Russell, S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 1993, 268 (3), 1908–1913. [PUBMED], [INFOTRIEVE]
  • Chakravortty, D.; Kato, Y.; Sugiyama, T.; Koide, N.; Mu, M.M.; Yoshida, T.; Yokochi, T. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J. Immunol. 2001, 166 (3), 2011–2017. [PUBMED], [INFOTRIEVE]
  • Pi, J.; Kumagai, Y.; Sun, G.; Yamauchi, H.; Yoshida, T.; Iso, H.; Endo, A.; Yu, L.; Yuki, K.; Miyauchi, T.; Shimojo, N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med. 2000, 28 (7), 1137–1142. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Vodovotz, Y.; Bogdan, C.; Paik, J.; Xie, Q.W.; Nathan, C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 1993, 178 (2), 605–613. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lantz, R. C.; Parliman, G.; Chen, G.J.; Carter, D.E. Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble as(III) and as(V). Environ. Res. 1994, 67 (2), 183–195. [PUBMED], [INFOTRIEVE], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.